PFAS are detected in essentially 100% of newborn cord blood samples across multiple biomonitoring studies. These forever chemicals cross the placenta during pregnancy, with short-chain compounds transferring more efficiently than older long-chain varieties. Cord blood PFAS levels reflect maternal exposure and may influence birth weight, thyroid function, and immune development in early life.
In a 2020 analysis of the Project Viva cohort, researchers found detectable PFAS in 100% of umbilical cord blood samples tested (Sagiv et al. 2020). Not 95%. Not 99%. Every single newborn.
This isn't a new finding. A landmark 2009 Environmental Working Group study detected 287 industrial chemicals in newborn cord blood, including PFOA, one of the most studied forever chemicals. When you sample cord blood from babies born in the United States, Europe, or China, the pattern holds: PFAS are there.
The question isn't whether babies are exposed. It's how much, which compounds, and what that means for their health in the first months and years of life.
The placenta acts as a filter between maternal and fetal blood, but it's not perfect. Some substances pass through easily. Others are blocked. PFAS fall somewhere in between.
PFAS molecules bind to serum albumin, a protein that carries fatty acids through the bloodstream. Because PFAS partially mimic the structure of natural fatty acids, they hitch a ride across the placental barrier. The body treats them like nutrients that belong there.
But here's where it gets counterintuitive: shorter PFAS molecules cross the placenta MORE efficiently than the older, longer-chain compounds we've been tracking for decades. According to studies of transplacental transfer efficiency, long-chain PFAS like PFOS and PFOA transfer at roughly 30-50% of maternal blood concentration. Short-chain replacements – compounds like GenX and PFBS that manufacturers switched to after PFOA phase-outs – transfer at higher rates because their smaller molecular size allows easier passage.
This matters because the chemical industry marketed short-chain PFAS as safer alternatives. Turns out, at least during pregnancy, they're more available to the fetus.
Once PFAS cross into fetal circulation, they don't distribute evenly. A 2019 Danish study by Mamsen and colleagues mapped PFAS concentrations in fetal organs from first-trimester tissue samples. The liver and lungs showed the highest accumulation.
The fetal liver is metabolically active – it's processing nutrients, producing bile, building protein. PFAS bind to liver proteins and accumulate there. Fetal lungs, still filled with amniotic fluid and preparing for that first breath, also concentrate these compounds.
Brain tissue showed lower but still detectable levels. Kidneys and intestines fell in the middle. The pattern suggests PFAS follow metabolic pathways – they end up where the body is doing the most biochemical work.
Cord blood PFAS concentrations range widely depending on maternal exposure. In the Project Viva cohort, median PFOA levels were around 2 ng/mL, with some samples reaching 8-10 ng/mL. PFOS levels ran slightly higher. Newer compounds like PFNA and PFHxS appeared at lower concentrations but were still nearly universal.
These numbers represent what the baby carried at birth – a snapshot of cumulative exposure during nine months of development. But cord blood levels also predict early-life health outcomes:
Birth weight: Multiple studies link higher cord blood PFAS to slightly lower birth weight, typically 50-150 grams per doubling of PFOA concentration. Not catastrophic, but measurable. (We cover this in detail in our pregnancy and PFAS overview.)
Thyroid disruption: PFAS interfere with thyroid hormone signaling. Some studies find lower levels of free T4 in newborns with higher cord blood PFAS, though effects are small and thyroid function usually normalizes within weeks.
Immune programming: The immune system takes shape during fetal development. Higher cord blood PFAS correlate with reduced antibody response to vaccines in early childhood – a finding that shows up across multiple cohorts and is one of the most consistent PFAS health effects.
None of these effects are dramatic on an individual level. But they're detectable, they're consistent across populations, and they represent changes happening during a critical developmental window.
When the EPA and industry groups phased out PFOA and PFOS in the early 2000s, manufacturers replaced them with shorter-chain alternatives – compounds with fewer carbon-fluorine bonds. The logic: shorter molecules should break down faster and accumulate less in the body.
That logic works for adult exposure. Short-chain PFAS do have shorter half-lives in blood – weeks to months instead of years. But during pregnancy, the opposite happens.
A 2018 study comparing maternal and cord blood ratios found that PFBS (a short-chain replacement) had a cord-to-maternal ratio of 0.8, meaning 80% of the mother's blood concentration transferred to the baby. PFOA, the older long-chain compound, transferred at around 0.4 – half as much.
GenX, another replacement chemical, shows similar high transfer efficiency. The smaller molecular size means easier passage through placental membranes, and the fetal liver doesn't eliminate these compounds as quickly as the adult liver does.
We replaced one set of forever chemicals with another set that crosses the placenta more readily. This is why biomonitoring studies from the last five years show rising cord blood levels of replacement PFAS even as PFOA levels decline.
The 2009 EWG cord blood study tested 10 babies born in U.S. hospitals. All 10 had PFOA. The median concentration: 1.6 ng/mL, roughly half the adult average at the time.
Fast forward to Project Viva (Boston-area births from 1999-2002, analyzed in 2020): 100% detection, median PFOA around 2 ng/mL. PFOS was even higher, averaging 3-4 ng/mL.
European cohorts show similar patterns. The Danish National Birth Cohort found PFAS in 100% of cord blood samples from over 1,500 pregnancies. The INMA cohort in Spain: same result. Chinese studies: same.
The universality is the striking part. This isn't a story about heavily contaminated communities or specific exposure sources. It's background exposure, distributed across the entire population, crossing the placenta in every pregnancy.
If you're pregnant or planning to become pregnant, here's what you can realistically do:
Check your water. PFAS exposure comes from multiple sources, but drinking water is the most controllable. Use our ZIP code tool to check local contamination levels. If PFAS are detected above EPA limits, switch to filtered or bottled water.
Use a certified filter. Reverse osmosis and activated carbon filters (NSF 53 or NSF 58 rated) remove most PFAS from drinking water. Pitcher filters vary – check the NSF certification.
Avoid stain-resistant products. Carpets, furniture, and clothing treated for stain or water resistance often contain PFAS. If you're buying new items for a nursery, ask about treatments and skip anything labeled "Scotchgard" or similar.
Skip nonstick cookware. Teflon and similar coatings can release PFAS when overheated. Cast iron, stainless steel, and ceramic are safer alternatives.
Don't panic about food packaging. Fast food wrappers and microwave popcorn bags were major PFAS sources a decade ago. Most U.S. manufacturers have phased them out, though some contamination persists. Eating home-cooked meals reduces exposure, but occasional takeout isn't a crisis.
You can't eliminate exposure entirely. PFAS are in the blood of 97% of Americans. You're starting from a baseline of contamination accumulated over your lifetime. Reducing NEW exposure during pregnancy helps, but you can't reverse what's already there.
For more pregnancy-specific guidance, see our PFAS and pregnancy hub.
Cord blood PFAS represent fetal exposure. But the story doesn't end at birth. PFAS also transfer through breast milk – typically at concentrations 3-5 times higher than maternal blood levels because PFAS concentrate in milk fat.
This creates a dilemma. Breastfeeding has massive health benefits for babies: immune support, cognitive development, bonding. The American Academy of Pediatrics and WHO both recommend breastfeeding despite PFAS presence.
The risk-benefit calculation strongly favors breastfeeding. We cover this trade-off in detail in our breastfeeding and PFAS article.
How long do PFAS stay in a baby's system after birth? Longer than in adults.
Adult PFOA half-life: 2-4 years. Adult PFOS half-life: 4-5 years. These are among the longest elimination times of any environmental chemical.
In newborns and infants, the data is sparser, but early studies suggest even longer retention. The kidneys and liver – organs that eliminate PFAS – are still maturing. Babies also have higher metabolic rates and faster cell turnover, which should speed elimination, but the overall balance still favors slow clearance.
One Swedish study tracking infants from birth to age 2 found that cord blood PFAS levels declined slowly over the first year, then plateaued. New exposure (primarily through breast milk) offset elimination.
By age 5, most children have PFAS levels similar to or slightly lower than adult averages. They've reached an equilibrium between ongoing environmental exposure and their body's ability to eliminate these chemicals.
Some research studies offer cord blood banking and testing, but it's not standard clinical practice. If you're participating in a birth cohort study, you might have the option. Otherwise, cord blood PFAS testing isn't something most hospitals offer.
You can test your own blood for PFAS through private labs (cost: $200-500), which gives a proxy for fetal exposure. Maternal blood PFAS typically run 2-3 times higher than cord blood for long-chain compounds, closer to 1:1 for short-chain.
But testing doesn't change the advice. Whether your levels are high or low, the steps to reduce exposure are the same: filter your water, avoid PFAS-treated products, eat home-cooked meals. Knowing your number might motivate action, but it doesn't open different interventions.
Cord blood biomonitoring has established that PFAS exposure is universal and begins before birth. What remains uncertain:
Long-term outcomes. Most studies track children through early childhood. Do cord blood PFAS predict health effects at age 10? Age 20? We don't know yet because the oldest cohorts are still young.
Mixture effects. Babies aren't exposed to one PFAS – they're exposed to 10-20 simultaneously. Do these chemicals act independently, or do they amplify each other's effects? Toxicology research is just beginning to untangle mixture toxicity.
Critical windows. Is first-trimester exposure more consequential than third-trimester? Do certain organ systems have sensitive periods? The Mamsen study mapping fetal tissue suggests the liver and lungs are vulnerable, but we don't know if there's a specific gestational week that matters most.
Replacement chemical safety. Short-chain PFAS have been in widespread use for less than 20 years. The health effects might not show up in epidemiological data for another decade.
This is one reason we keep updating our pregnancy content as new research emerges.
PFAS in cord blood is a population-level problem, not an individual crisis. Every baby is born with measurable forever chemicals. Some are exposed to more, some to less, but no one escapes.
The health effects we can measure so far – small reductions in birth weight, subtle immune changes – are concerning at a public health scale but hard to detect in individual pregnancies. You can't prevent exposure entirely, but you can minimize NEW exposure during pregnancy by filtering water, avoiding PFAS-treated products, and making informed consumer choices.
If you're pregnant now, the single best action: check whether PFAS are in your drinking water. Enter your ZIP code here to see local contamination levels and whether you should switch to filtered water.
Are all babies born with PFAS in their blood? Yes, according to biomonitoring studies in the U.S. Europe, and China. The Project Viva cohort found detectable PFAS in 100% of cord blood samples tested. Background environmental contamination is so widespread that prenatal exposure is now universal. Concentrations vary based on maternal exposure, but detection itself is nearly guaranteed.
Can I do anything to lower my baby's exposure to PFAS during pregnancy? You can reduce new exposure but not eliminate what's already in your body. Filter drinking water with a reverse osmosis or NSF-certified carbon filter. Avoid stain-resistant furniture and carpets. Skip nonstick cookware. Eat home-cooked meals to minimize food packaging exposure. These steps won't zero out PFAS, but they limit accumulation during pregnancy.
Why do short-chain PFAS transfer across the placenta more than long-chain PFAS? Short-chain PFAS like GenX and PFBS have smaller molecular structures that pass through placental membranes more easily. Studies show cord-to-maternal blood ratios of 0.7-0.8 for short-chain compounds versus 0.3-0.5 for long-chain PFOA and PFOS. The industry replaced older PFAS with shorter alternatives that turned out to cross the placenta more efficiently.
Is cord blood testing for PFAS available? Not through standard medical care. Some research studies offer cord blood banking with PFAS testing, but it's not a routine hospital service. You can test your own blood through private labs ($200-500), which provides a rough proxy since maternal levels run 2-3 times higher than cord blood for most compounds.
How long do PFAS stay in a newborn's body? Longer than in adults. PFOA has a half-life of 2-4 years in adults; PFOS is 4-5 years. Newborns appear to eliminate PFAS even more slowly because their kidneys and liver are still developing. One Swedish study found cord blood PFAS levels declined slowly over the first year but remained detectable through early childhood.